These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25194765)

  • 1. Oral anticoagulants for stroke prevention in atrial fibrillation. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2014 Sep; 39(9):317. PubMed ID: 25194765
    [No Abstract]   [Full Text] [Related]  

  • 2. [New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation].
    Bosch M; Llop R; Lalueza P; Villar Mdel M
    Med Clin (Barc); 2013 Mar; 140(5):229-31. PubMed ID: 23276615
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress for stroke prevention with atrial fibrillation: emergence of alternative oral anticoagulants.
    Katsnelson M; Sacco RL; Moscucci M
    Stroke; 2012 Apr; 43(4):1179-85. PubMed ID: 22454426
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?
    Foley J; Lip GY
    Int J Clin Pract; 2012 May; 66(5):422-4. PubMed ID: 22512602
    [No Abstract]   [Full Text] [Related]  

  • 6. Updated NICE guideline: management of atrial fibrillation (2014).
    Senoo K; Lau YC; Lip GY
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1037-40. PubMed ID: 25059099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant therapy in atrial fibrillation: vitamin K antagonists or novel oral anticoagulant drugs?
    Riva N; Borg Xuereb C; Ageno W
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):139-41. PubMed ID: 25539157
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
    Fernandez MM; von Schéele B; Hogue S; Kwong WJ
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
    Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation in atrial fibrillation: are the problems solved?
    Doğan U
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):41-2. PubMed ID: 20150003
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case report.
    Rohla M; Freynhofer MK; Hammerl H; Weiss TW; Huber K
    Thromb Haemost; 2014 Feb; 111(2):375-8. PubMed ID: 24136295
    [No Abstract]   [Full Text] [Related]  

  • 14. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel oral anticoagulants for stroke prevention in the geriatric population.
    Kim D; Barna R; Bridgeman MB; Brunetti L
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):15-29. PubMed ID: 24234513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time?
    Tzikas A; Freixa X; Ibrahim R
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1587-9. PubMed ID: 24215187
    [No Abstract]   [Full Text] [Related]  

  • 17. Current evidence for new oral anticoagulants in the treatment of nonvalvular atrial fibrillation: comparison of substudies.
    Martínez-Rubio A; Martínez-Torrecilla R
    Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):185-9. PubMed ID: 25449814
    [No Abstract]   [Full Text] [Related]  

  • 18. The introduction of novel oral anticoagulants in 2009 has been rightly heralded as a major therapeutic breakthrough.
    Pachinger O
    Wien Klin Wochenschr; 2014 Nov; 126(21-22):691. PubMed ID: 25398295
    [No Abstract]   [Full Text] [Related]  

  • 19. [Should all patients with atrial fibrillation and CHA2DS2-VASc score 1 receive oral anticoagulation?].
    Di Pasquale G; Zagnoni S
    G Ital Cardiol (Rome); 2015 Nov; 16(11):608-12. PubMed ID: 26571473
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Challenges of Using Novel Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.
    Nazeri A
    Tex Heart Inst J; 2018 Jun; 45(3):164-165. PubMed ID: 30072853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.